Investors and traders are waking up to the first full trading week of 2017 with a handful of companies issuing preliminary
guidance.
Given the wide range of market capitalization sizes and completely different industries the companies operate in, it would be
difficult to make the case for any macro-wide trends around the health of the economy or individual sectors based on the respective
companies announcements.
Iridex
IRIDEX Corporation (NASDAQ: IRIX), a provider of
therapeutic based laser consoles, said that it expects its fourth-quarter revenue to fall in a range of $12.4 million to $12.5
million, which is short of Wall Street's expectations of $12.6 million.
The company also guided its full fiscal year 2016 revenue to be in a range of $46.0 million to $46.1 million versus Wall
Street's expectations of $46.08 million.
Lululemon
Lululemon Athletica (NASDAQ: LULU), the maker of
"athleisurewear," revised the lower end of its fourth-quarter guidance
higher on Monday.
The company said it now expects to earn $0.99 to $1.01 per share in the fourth quarter on revenue of $775.0 million to $785.0
million. This represents an increase from the company's prior outlook of earning $0.96 to $1.01 per share on revenue of $765.0
million to $785.0 million.
Wall Street analysts are currently projecting Lululemon to earn $1.00 per share in the fourth quarter on revenue of $782.0
million.
SeaSpine Holdings
SeaSpine Holdings Corp (NASDAQ: SPNE), a medical technology company that focuses on treating patients with spinal
disorders, issued fourth-quarter and full-year sales guidance.
The company expects its fourth quarter revenue to fall in a range of $32.5 million to $32.7 million and its full fiscal year
2016 revenue to fall in a range of $128.0 million to $129.0 million.
Wall Street analysts are expecting the company's fourth-quarter revenue to be $32.6 million and $129.9 million for the full
year.
At Home Group
At Home Group Inc (NYSE: HOME), a home decor
superstore with 115 format stores across 29 states, issued full-year guidance.
The company expects to earn $0.55 to $0.57 per share for the full-year fiscal 2017 on revenue of $758.0 million to $761.0
million. There are currently no estimates for the company.
Teladoc
Teladoc Inc (NYSE: TDOC), a provider of on-demand
healthcare services through the internet and mobile devices, offered preliminary fiscal 2016 guidance and an outlook to the coming
year as part of the company's presentation at the JPMorgan
Healthcare Conference.
Teladoc expects its full-year fiscal 2016 revenue to be $123 million, which is above Wall Street's expectations of $122.18
million. The company guided its full fiscal year 2017 revenue to be in a range of $180.0 million to $185.0 million, which falls
short of Wall Street's expectations of $185.83 million.
© 2017 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.